Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Cheetham

Showing results (21-30 of 96) with videos related to

Pageof 10
Sort By:
Clinical Science (London, England : 1979)|December 15, 2000
Losartan, an angiotensin type I receptor antagonist, improves conduit vessel endothelial function in Type II diabetesC Cheetham, G O'Driscoll, K Stanton, et al.
Epidemiology and Infection|November 18, 1997
An outbreak of infection due to verocytotoxin-producing Escherichia coli O157 in four families: the influence of laboratory methods on the outcome of the investigationP A Chapman, C A Siddons, J Manning, et al.
Optics Express|February 8, 2013
Fizeau interferometric cophasing of segmented mirrorsAnthony C Cheetham, Peter G Tuthill, Anand Sivaramakrishnan, et al.
Pharmacology, Biochemistry, and Behavior|August 1, 1995
Dopamine D2 receptors: a potential pharmacological target for nomifensine and tranylcypromine but not other antidepressant treatmentsK F Martin, I Phillips, S C Cheetham, et al.
Protein Engineering|January 1, 1993
The prediction and characterization of metal binding sites in proteinsD S Gregory, A C Martin, J C Cheetham, et al.
Journal of Neural Transmission. General Section|January 1, 1995
D1 receptor binding in rat striatum: modification by various D1 and D2 antagonists, but not by sibutramine hydrochloride, antidepressants or treatments which enhance central dopaminergic functionS C Cheetham, C J Kettle, K F Martin, et al.
Journal of the American College of Cardiology|November 18, 2000
Losartan, an angiotensin type 1 receptor antagonist, improves endothelial function in non-insulin-dependent diabetesC Cheetham, J Collis, G O'Driscoll, et al.
Neuropharmacology|August 30, 2000
Sibutramine does not decrease the number of 5-HT re-uptake sites in rat brain and, like fluoxetine, protects against the deficits produced by dexfenfluramineS C Cheetham, J A Viggers, N A Slater, et al.
Australian Nursing Journal (July 1993)|January 21, 2011
Heart Health: new ways to deliver cardiac rehabilitationL Dimer, J Jones, T Dowling, et al.
European Journal of Pharmacology|August 29, 1989
Beta-adrenoceptors in human brain labelled with [3H]dihydroalprenolol and [3H]CGP 12177F De Paermentier, S C Cheetham, M R Crompton, et al.
Pageof 10

Showing results (21-30 of 96) with videos related to

Sort By:
Pageof 10
Clinical Science (London, England : 1979)|December 15, 2000
Losartan, an angiotensin type I receptor antagonist, improves conduit vessel endothelial function in Type II diabetesC Cheetham, G O'Driscoll, K Stanton, et al.
Epidemiology and Infection|November 18, 1997
An outbreak of infection due to verocytotoxin-producing Escherichia coli O157 in four families: the influence of laboratory methods on the outcome of the investigationP A Chapman, C A Siddons, J Manning, et al.
Optics Express|February 8, 2013
Fizeau interferometric cophasing of segmented mirrorsAnthony C Cheetham, Peter G Tuthill, Anand Sivaramakrishnan, et al.
Pharmacology, Biochemistry, and Behavior|August 1, 1995
Dopamine D2 receptors: a potential pharmacological target for nomifensine and tranylcypromine but not other antidepressant treatmentsK F Martin, I Phillips, S C Cheetham, et al.
Protein Engineering|January 1, 1993
The prediction and characterization of metal binding sites in proteinsD S Gregory, A C Martin, J C Cheetham, et al.
Journal of Neural Transmission. General Section|January 1, 1995
D1 receptor binding in rat striatum: modification by various D1 and D2 antagonists, but not by sibutramine hydrochloride, antidepressants or treatments which enhance central dopaminergic functionS C Cheetham, C J Kettle, K F Martin, et al.
Journal of the American College of Cardiology|November 18, 2000
Losartan, an angiotensin type 1 receptor antagonist, improves endothelial function in non-insulin-dependent diabetesC Cheetham, J Collis, G O'Driscoll, et al.
Neuropharmacology|August 30, 2000
Sibutramine does not decrease the number of 5-HT re-uptake sites in rat brain and, like fluoxetine, protects against the deficits produced by dexfenfluramineS C Cheetham, J A Viggers, N A Slater, et al.
Australian Nursing Journal (July 1993)|January 21, 2011
Heart Health: new ways to deliver cardiac rehabilitationL Dimer, J Jones, T Dowling, et al.
European Journal of Pharmacology|August 29, 1989
Beta-adrenoceptors in human brain labelled with [3H]dihydroalprenolol and [3H]CGP 12177F De Paermentier, S C Cheetham, M R Crompton, et al.
Pageof 10